I find AWS extremely difficult to use compared to GCP. Even though we received startup credits—which are essentially free money—we’re letting them go to waste because the platform is so much harder to work with.
It’s no surprise that AWS’s revenue growth is lagging behind GCP and Azure.
Beyond the AI talent gap, Amazon seems to be making serious missteps in its own core business.
It reminds me of Apple. At first, people thought Apple was being strategic by staying out of the AI race and waiting to pick the winner. But in reality, it turned out to be an inability to adapt to the new trend. I expect the same pattern from Amazon.
Market disruption is the key difference. We now know how CPU operate and it's almost taken as a commodity.
Before Telsa, nobody thoughts electric cars were ready for road. Before SpaceX, I don't think anyone tried reusable rocket thingy. The thing is when you come up with a radically new idea, you have to know enough about it to convince others to work on it.
Steve Jobs knew enough about computer(and general idea of programming) to sell it, and Bill Gates was once a good programmer. Intel, nVidia founder were also chip engineers.
4-member family house rent/buy ratio in Korea is really high because of its unique Jeonse system: https://en.wikipedia.org/wiki/Jeonse Nobody rents 4 member family house because rent is more than mortgage.
On the other hand, bachelor studio is rather cheap even in the downtown Seoul(like 1k USD per month at most)
Jeonse system is unique in Korea and it really weird. It took me a few years to understand it and it shouldn't really work anymore because the housing price has stabilized in last 4 decades or so.
The point being, any of these commentors here who haven't heard of Jeonse, they don't know anything about housing in South Korea.
If Google jacks up the price of TPU or terminate the TPU usage because they don't like you, you're screwed. It's quite a high risk for commercial product companies.
According to Wikipedia, "As of November 2020, Moderna was valued at $35 billion, and while none of its drugs had been approved" since its creation in 2010.
$38bn ain't bad for a company without a single product released for the past 10 years.
Earnings per share is only useful when you look at the stock price. Since number of outstanding shares are different between two companies, it's incorrect to measure company's profit based on EPS.
Ah, I misspoke. I meant prjeddie. prjeddie kind of endorsed YOLOv4. Did he endorse YOLOv5?
Although YOLOv4 isn't anything new achitecture-wise, it tried all the tricks in the book on the existing YOLO architecture to increase its speed performance, and its method and experiment results were published as a paper; it provided value to humanity.
YOLOv5 seemed to have taken the YOLO name to seemingly only to increase the startup name value without giving much(it did appear to provided YOLOv3 Pytorch implementation, but that's before taking YOLOv5 name) back. I wonder how prjeddie would think of YOLOv5.